Shabnam Ford

FDA

2 appearances in the program

Sessions & presentations

PS39:Contributions of Phases: Statistical Considerations in Study Designs and Regulatory Perspectives

Presentation: Demonstrating Contribution of Components in Multi-Drug Regimens and Contribution of Phase in Sequenced Therapy: Why It Matters and How to Assess It

Parallel · Fri, Sep 26 , 10:45 AM

Presenting Author

PS39:Contributions of Phases: Statistical Considerations in Study Designs and Regulatory Perspectives

Presentation: Panel Discussion: Assessing Contribution of Phases: Challenges and Opportunities

Parallel · Fri, Sep 26 , 10:45 AM

Panelist